Symbyax is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Olanzapine; Fluoxetine Hydrochloride.
Product ID | 0002-3230_087c16dc-e0c2-4c5b-8cc8-f703a992f5d9 |
NDC | 0002-3230 |
Product Type | Human Prescription Drug |
Proprietary Name | Symbyax |
Generic Name | Olanzapine And Fluoxetine Hydrochloride |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2007-04-09 |
Marketing Category | NDA / NDA |
Application Number | NDA021520 |
Labeler Name | Eli Lilly and Company |
Substance Name | OLANZAPINE; FLUOXETINE HYDROCHLORIDE |
Active Ingredient Strength | 3 mg/1; mg/1 |
Pharm Classes | Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2007-04-09 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021520 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-04-09 |
Marketing Category | NDA |
Application Number | NDA021520 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-06-29 |
Marketing End Date | 2014-04-02 |
Ingredient | Strength |
---|---|
OLANZAPINE | 3 mg/1 |
SPL SET ID: | 6b28c424-0b7e-4b75-b090-f116b113554e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0002-3230 | Symbyax | Olanzapine and Fluoxetine hydrochloride |
0002-3231 | Symbyax | Olanzapine and Fluoxetine hydrochloride |
0002-3232 | Symbyax | Olanzapine and Fluoxetine hydrochloride |
0002-3233 | Symbyax | Olanzapine and Fluoxetine hydrochloride |
0002-3234 | Symbyax | Olanzapine and Fluoxetine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SYMBYAX 76230425 2926531 Live/Registered |
Eli Lilly and Company 2001-03-26 |